301207.SZ
华兰疫苗
SZSE · Healthcare · C 制造业 · CN
CNY 17.08
−4.31%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
—
Market Cap
CNY 10.27B
MomentumView details →
1D Return
−4.31%
YTD Return
−8.05%
RSI (14)
45.6
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
—
Market Cap
CNY 10.27B
RSI (14)
45.6
MomentumView details →
1D Return
−4.31%
YTD Return
−8.05%
Similar companies
Latest newsMore news →
Hualan Biological Vaccine Inc. proposed a cash dividend of 1 yuan per 10 shares (tax included) based on a base of 595 million shares, with no bonus shares and no capital reserve conversion.8d agoHualan Biological Vaccine Inc. announced its first-half 2026 results: net profit attributable to shareholders was 36.4432 million yuan, up 75.23% year-on-year, with revenue of 44.3853 million yuan, down 25.98%.8d ago